• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

作者信息

Louissaint Jeremy, Deutsch-Link Sasha, Tapper Elliot B

机构信息

Center for Liver Disease and Transplantation, Columbia University, New York, New York.

Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina.

出版信息

Clin Gastroenterol Hepatol. 2022 Aug;20(8S):S1-S8. doi: 10.1016/j.cgh.2022.04.036.

DOI:10.1016/j.cgh.2022.04.036
PMID:35940729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9531320/
Abstract
摘要

相似文献

1
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.肝硬化和肝性脑病不断变化的流行病学
Clin Gastroenterol Hepatol. 2022 Aug;20(8S):S1-S8. doi: 10.1016/j.cgh.2022.04.036.
2
The Health Care Burden of Hepatic Encephalopathy.肝性脑病的医疗负担。
Clin Liver Dis. 2024 May;28(2):265-272. doi: 10.1016/j.cld.2024.01.009. Epub 2024 Feb 12.
3
Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.肝性脑病作为肝硬化的并发症：亚洲视角。
J Gastroenterol Hepatol. 2010 May;25(5):858-63. doi: 10.1111/j.1440-1746.2010.06242.x.
4
Letter: diabetes mellitus increases the risk of hepatic encephalopathy in patients with cirrhosis.信函：糖尿病会增加肝硬化患者发生肝性脑病的风险。
Aliment Pharmacol Ther. 2020 Oct;52(7):1257. doi: 10.1111/apt.16015.
5
Letter: diabetes mellitus increases the risk of hepatic encephalopathy in patients with cirrhosis-authors' reply.信函：糖尿病增加肝硬化患者肝性脑病风险——作者回复
Aliment Pharmacol Ther. 2020 Oct;52(7):1258. doi: 10.1111/apt.16018.
6
Epidemiology of Hepatic Encephalopathy.肝性脑病的流行病学。
Clin Liver Dis. 2020 May;24(2):157-174. doi: 10.1016/j.cld.2020.01.001. Epub 2020 Mar 2.
7
Minimal hepatic encephalopathy in noncirrhotic portal hypertension.非肝硬化门静脉高压症中的轻微肝性脑病
Eur J Gastroenterol Hepatol. 2011 Feb;23(2):194-5. doi: 10.1097/MEG.0b013e3283427e19.
8
Diagnosing minimal hepatic encephalopathy: from the ivory tower to the real world.诊断轻微肝性脑病：从象牙塔到现实世界。
Gastroenterology. 2015 Nov;149(6):1330-3. doi: 10.1053/j.gastro.2015.09.028. Epub 2015 Sep 28.
9
Hepatic encephalopathy.肝性脑病。
Saudi J Gastroenterol. 2012 Sep-Oct;18(5):301-9. doi: 10.4103/1319-3767.101123.
10
Hepatic Encephalopathy and Nutrition Influences: A Narrative Review.肝性脑病与营养影响：综述
Nutr Clin Pract. 2020 Feb;35(1):36-48. doi: 10.1002/ncp.10458. Epub 2019 Dec 23.

引用本文的文献

1
Simple scoring model for predicting overt hepatic encephalopathy in geriatric cirrhosis: A multicenter retrospective cohort study.预测老年肝硬化患者显性肝性脑病的简易评分模型：一项多中心回顾性队列研究。
Metab Brain Dis. 2025 Sep 10;40(7):263. doi: 10.1007/s11011-025-01691-x.
2
A Machine Learning-Based Prognostication Model Enhances Prediction of Early Hepatic Encephalopathy in Patients With Noncancer-Related Cirrhosis: Multicenter Longitudinal Cohort Study in Taiwan.基于机器学习的预后模型可增强对非癌性肝硬化患者早期肝性脑病的预测：台湾多中心纵向队列研究
JMIR Med Inform. 2025 Aug 6;13:e71229. doi: 10.2196/71229.
3
Identification of multiple complications as independent risk factors associated with 1-, 3-, and 5-year mortality in hepatitis B-associated cirrhosis patients.

本文引用的文献

1
Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United States.美国肝性脑病患者使用利福昔明和转至各亚专科的种族和民族差异。
J Hepatol. 2022 Aug;77(2):377-382. doi: 10.1016/j.jhep.2022.02.010. Epub 2022 Mar 30.
2
An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.电子决策支持干预可降低肝硬化患者的再入院率。
Am J Gastroenterol. 2022 Mar 1;117(3):491-494. doi: 10.14309/ajg.0000000000001608.
3
Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action.
确定多种并发症为乙型肝炎相关性肝硬化患者1年、3年和5年死亡率的独立危险因素。
BMC Infect Dis. 2025 Feb 1;25(1):151. doi: 10.1186/s12879-025-10566-6.
4
Real-World Trends and Future Projections of the Prevalence of Cirrhosis and Hepatic Encephalopathy Among Commercially and Medicare-Insured Adults in the United States.美国商业保险和医疗保险覆盖的成年人中肝硬化和肝性脑病患病率的真实世界趋势及未来预测
Clin Transl Gastroenterol. 2025 Jan 21;16(5). doi: 10.14309/ctg.0000000000000823.
5
Ammonia and beyond - biomarkers of hepatic encephalopathy.氨及其他——肝性脑病的生物标志物
Metab Brain Dis. 2025 Jan 15;40(1):100. doi: 10.1007/s11011-024-01512-7.
6
Intravenous branched-chain amino acid administration for the acute treatment of hepatic encephalopathy: a systematic review and meta-analysis.静脉输注支链氨基酸用于肝性脑病的急性治疗：一项系统评价和荟萃分析。
J Intensive Care. 2025 Jan 9;13(1):2. doi: 10.1186/s40560-024-00771-x.
7
Stem cell transplantation therapy for advanced liver damage-associated neurodegenerative disorders.用于晚期肝损伤相关神经退行性疾病的干细胞移植疗法。
Int J Surg. 2024 Nov 1;110(11):6873-6882. doi: 10.1097/JS9.0000000000002001.
8
Systems of care that improve outcomes for people with hepatic encephalopathy.改善肝性脑病患者治疗效果的照护体系。
Metab Brain Dis. 2024 Dec 2;40(1):50. doi: 10.1007/s11011-024-01430-8.
9
Correlation of ammonia and blood laboratory parameters with hepatic encephalopathy: A systematic review and meta-analysis.氨与血液实验室参数与肝性脑病的相关性：系统评价和荟萃分析。
PLoS One. 2024 Sep 3;19(9):e0307899. doi: 10.1371/journal.pone.0307899. eCollection 2024.
10
Thyroxine Levels Predict the Development of Brain Failure in Patients With Cirrhosis in Indian Population.甲状腺素水平可预测印度人群肝硬化患者脑功能衰竭的发生。
Gastro Hep Adv. 2023 Sep 25;3(1):55-57. doi: 10.1016/j.gastha.2023.09.009. eCollection 2024.
慢性肝脏疾病门诊患者阿片类药物处方的特征：行动呼吁。
PLoS One. 2021 Dec 17;16(12):e0261377. doi: 10.1371/journal.pone.0261377. eCollection 2021.
4
Effect of increased alcohol consumption during COVID-19 pandemic on alcohol-associated liver disease: A modeling study.新冠大流行期间饮酒量增加对酒精性肝病的影响：一项建模研究。
Hepatology. 2022 Jun;75(6):1480-1490. doi: 10.1002/hep.32272. Epub 2022 Jan 24.
5
National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017.2002 - 2017年美国处方质子泵抑制剂使用情况及支出的全国趋势。
J Am Pharm Assoc (2003). 2020 Oct 22. doi: 10.1016/j.japh.2020.09.015.
6
A Policy Prescription for Reducing Health Disparities-Achieving Pharmacoequity.减少健康差距——实现药物公平的政策处方
JAMA. 2021 Nov 9;326(18):1793-1794. doi: 10.1001/jama.2021.17764.
7
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病成人患者结局的前瞻性研究。
N Engl J Med. 2021 Oct 21;385(17):1559-1569. doi: 10.1056/NEJMoa2029349.
8
Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study.丙型肝炎的消除可改善肝硬化或非肝硬化患者的认知功能：一项前瞻性真实世界研究。
Eur J Neurol. 2022 Feb;29(2):400-412. doi: 10.1111/ene.15138. Epub 2021 Nov 2.
9
COVID-19 Aftershocks on Alcohol-Associated Liver Disease: An Early Cross-Sectional Report From the U.S. Epicenter.COVID-19对酒精性肝病的后续影响：来自美国疫情中心的早期横断面报告
Hepatol Commun. 2021 Jul;5(7):1151-1155. doi: 10.1002/hep4.1706. Epub 2021 Apr 7.
10
Impact of Hepatic Encephalopathy on Clinical Characteristics and Adverse Outcomes in Prospective and Multicenter Cohorts of Patients With Acute-on-Chronic Liver Diseases.肝性脑病对慢性肝病急性发作患者前瞻性多中心队列临床特征及不良结局的影响
Front Med (Lausanne). 2021 Aug 2;8:709884. doi: 10.3389/fmed.2021.709884. eCollection 2021.